BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30191883)

  • 1. Erratum to: Comparison of Adjuvant Versus Salvage Radiotherapy Policies for Postprostatectomy Radiotherapy. Int J Radiat Oncol Biol Phys 2004;59:329-340.
    Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):471. PubMed ID: 30191883
    [No Abstract]   [Full Text] [Related]  

  • 2. In regards to Dr. Glatstein Int J Radiat Oncol Biol Phys 2003;55:561-562, and Dr. Amols, Int J Radiat Oncol Biol Phys 2003;56:1507.
    Nutting C; Harrington K
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1316-7; author reply 1317. PubMed ID: 15001278
    [No Abstract]   [Full Text] [Related]  

  • 3. In regard to Chen et Al. (Int J Radiat Oncol Biol Phys 2007;69:25-31) and Chao et Al. (Int j Radiat Oncol Biol Phys 2007;69:32-40).
    Yaeger TE
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):317; author reply 317-8. PubMed ID: 18406902
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjuvant malignant mesothelioma radiotherapy: How many difficulties! In regard to: Allen et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma (Int J Radiat Oncol Biol Phys 2006;65:640-645) and Gupta et al. Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma (Int J Radiat Oncol Biol Phys 2005;63:1045-1052).
    Russi EG; Pergolizzi S; Lucio F; Ricardi U
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1273-4; author reply 1274. PubMed ID: 17145545
    [No Abstract]   [Full Text] [Related]  

  • 5. Radiotherapy in pleural malignant mesothelioma: why not! In regard to Scorsetti et al. (Int J Radiat Oncol Biol Phys 2010;77:942-949); Krayenbuehl et al. (Int J Radiat Oncol Biol Phys 2010;78:628-634).
    Russi EG; Numico G; Ricardi U
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1279; author reply 1279-80. PubMed ID: 21353165
    [No Abstract]   [Full Text] [Related]  

  • 6. Lung V20 measurements: In regard to Seppenwoolde et al. (Int J Radiat Oncol Biol Phys 2003;55:724-735), and Tsujino et al. (Int J Radiat Oncol Biol Phys 2003;56:1208-1209).
    Garces YI; Miller RC
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1636; author reply 1636-7. PubMed ID: 15050346
    [No Abstract]   [Full Text] [Related]  

  • 7. Response to "Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation" (Int J Radiat Oncol Biol Phys 2010;76:71-78) and "Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation" Int J Radiat Oncol Biol Phys 2009;75:1290-1296).
    Wolmark N; Curran WJ; Vicini F; White J; Costantino JP; Arthur D; Kuske R; Rabinovitch R; Julian TB; Parda DS
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):317; author reply 318. PubMed ID: 20394863
    [No Abstract]   [Full Text] [Related]  

  • 8. What is the target volume for preoperative accelerated partial breast irradiation (APBI)? In regards to Nichols et al. (Int J Radiat Oncol Biol Phys 2010;77:197-202) and Palta et al. (Int J Radiat Oncol Biol Phys 2010, in Press).
    Kim L; Shaitelman S
    Int J Radiat Oncol Biol Phys; 2011 May; 80(1):314-5; author reply 315-6. PubMed ID: 21481727
    [No Abstract]   [Full Text] [Related]  

  • 9. What approach will lead to cure of glioblastoma multiforme? In regard to Barani et al. (Int J Radiat Oncol Biol Phys 2007;68:324-333) and Jones and Sanghera (Int J Radiat Oncol Biol Phys 2007;68:441-448).
    Nieder C
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):640-1; author reply 641. PubMed ID: 17869682
    [No Abstract]   [Full Text] [Related]  

  • 10. Response to "Stereotactic ablative radiotherapy in the framework of classical radiobiology: response to Drs. Brown, Diehn, and Loo." (Int J Radiat Oncol Biol Phys 2011;79:1599-1600) and "Influence of tumor hypoxia on stereotactic ablative radiotherapy (SABR): response to Drs. Mayer and Timmerman." (Int J Radiation Oncol Biol Phys 2011;78:1600).
    Song CW; Levitt SH; Park H
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1193; author reply 1193-4. PubMed ID: 22036162
    [No Abstract]   [Full Text] [Related]  

  • 11. Randomized comparison of whole brain radiotherapy, 20 Gy in four daily fractions versus 40 Gy in 20 twice-daily fractions, for brain metastases. In regard to Graham et al. (Int J Radiat Oncol Biol Phys 2010;77(3):648-54.).
    Davey P; Smith J; Ennis M
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1605-6; author reply 1606. PubMed ID: 21092835
    [No Abstract]   [Full Text] [Related]  

  • 12. Erratum to: Baumann BC, Bosch WR, Bahl A, et al. Development and validation of consensus contouring guidelines for adjuvant radiation therapy for bladder cancer after radical cystectomy. Int J Radiat Oncol Biol Phys 2016;96:78-86.
    Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1129. PubMed ID: 27869092
    [No Abstract]   [Full Text] [Related]  

  • 13. Determination of TGF-beta1 plasma levels: In regard to Anscher et al. (Int J Radiat Oncol Biol Phys 2003;56: 988-995) and de Jaeger et al (Int J Radiat Oncol Biol Phys 2004;58: 1378-1387).
    Barthelemy-Brichant N
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1339; author reply 1339-40. PubMed ID: 15519811
    [No Abstract]   [Full Text] [Related]  

  • 14. Salvage radiotherapy in patients with PET-Positive residual non-Hodgkin's lymphoma after chemotherapy: in regard to Kahn et al. (Int J Radiat Oncol Biol Phys 2006;66:961-965).
    Nieder C; Andratschke N
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1278; author reply 1278. PubMed ID: 17336228
    [No Abstract]   [Full Text] [Related]  

  • 15. Erratum to: Reddy J, Lei X, Bloom S, et al. Optimizing Preventive Adjuvant Linac-Based (OPAL) Radiation: A Phase 2 Trial of Daily Partial Breast Irradiation. Int J Radiat Oncol Biol Phys 2024;115(3): 629-644.
    Int J Radiat Oncol Biol Phys; 2024 Jul; 119(3):1034. PubMed ID: 38851265
    [No Abstract]   [Full Text] [Related]  

  • 16. In regard to Dr. Ortholan et al. (Int J Radiat Oncol Biol Phys 2005;61:154-162).
    de Dios NR; Lopez MA; Latiesas XS; Arnalot PF
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):616; author reply 616. PubMed ID: 15890612
    [No Abstract]   [Full Text] [Related]  

  • 17. In regards to: Adjuvant radiotherapy after transoral laser microsurgery for advanced squamous cell carcinoma of the head and neck by Pradier et al. (Int J Radiat Oncol Biol Phys 2005;63:1368-1377).
    Cengiz M; Ozyar E; Genc M
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):955; author reply 955-6. PubMed ID: 16751078
    [No Abstract]   [Full Text] [Related]  

  • 18. Erratum to: Blitzblau RC, Horton JK. First, Do No Harm. Int J Radiat Oncol Biol Phys 2019;103:295-296.
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):701. PubMed ID: 30928359
    [No Abstract]   [Full Text] [Related]  

  • 19. Response to "Timing of radiotherapy and outcome in patients receiving adjuvant endocrine therapy." (Int J Radiat Oncol Biol Phys 2011;80:398-402).
    Tsoutsou PG; Jeanneret Sozzi W; Ozsahin M
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):519; author reply 519-20. PubMed ID: 22244276
    [No Abstract]   [Full Text] [Related]  

  • 20. Adjuvant whole brain radiotherapy: strong emotions decide but rationale studies are needed: in regard to Brown et al. (Int J Radiat Oncol Biol Phys 2008;70:1305-1309).
    Larson D; Sahgal A
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):959. PubMed ID: 19014787
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.